Vidaza

List of products in the National Drug Code with proprietary name vidaza. This medication is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells. People with MDS usually have problems such as infections, anemia, and easy bleeding/bruising. Azacitidine is believed to work by helping your bone marrow grow normal blood cells so you will need fewer blood transfusions. Azacitidine also kills abnormal blood cells that have grown too fast and do not work properly.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
59572-102Vidaza AzacitidineInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousCelgene CorporationHuman Prescription Drug